الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 137 |  |  |
| | | from | 137 | | |
Abstract
HCC is one of the most common cancer types worldwide. Hepatocellular cancer ranks fifth among cancers and is related to chronic viral hepatitis, alcohol abuse, steatohepatitis and liver autoimmunity.
Our retrospective study was carried out to determine the success rate and predictors of good ablation in patients with small hepatocellular carcinoma treated by RF in endoscope unit of the Suez Canal University Hospitals (The hospital of Suez Canal region and Sinai) through the period from 2010 to 2018.
All patients who were presented by small hepatic focal lesions and diagnosed to be hepatocellular carcinoma then treated by radiofrequency in the endoscope unit of Suez Canal University Hospitals for patients who were refereed from Suez Canal region and Sinai through the period from 2010 to 2018 (they are about 300 patients).
Including, all patients who were presented with small hepatic focal lesions and diagnosed to be hepatocellular carcinoma then treated by radiofrequency were involved in the study according to BCLC protocols.
Excluding, patients with advanced HCC, distant metastasis, child C patients and advanced, co morbid condition as renal failure, heart failure, bleeding diathesis as thrombocytopenia (Platelet counts below 60,000/ c.c), prolonged prothrombin time (INR>1.5), or portal vein invasion.
The most frequent presenting signs were abdominal tenderness in 105 (35%) of cases, splenomegaly in 88 (29.3%), LL edema in 59 (19.7%), jaundice in 25 (8.3%), hepatomegaly in 20 (6.7%), and lymphadenopathy in 3 (1%).